Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

E-ISSN： 1365-2125|79|5|838-846

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.79, Iss.5, 2015-05, pp. : 838-846

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rivaroxaban, a new oral factor Xa inhibitor, provides new data on anticoagulation

By Siddique Aurangzeb Lip Gregory YH Shantsila Eduard

Therapy, Vol. 6, Iss. 2, 2009-03 ,pp. : 187-189

Future Medicine

Access to resources Recommend Favorite

Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers

By Huang H.-L. A. Vaidyanathan S. Yeh C.-M. Bizot M.-N. Dieterich H. A. Dole W. P. Howard D.

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2449-2456

Informa Healthcare

Access to resources Recommend Favorite

Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 121-128

John Wiley & Sons Inc

Access to resources Recommend Favorite

Indirect and direct anticoagulants predominantly inhibiting factor Xa

By Harenberg Job

Therapy, Vol. 5, Iss. 2, 2008-03 ,pp. : 177-192

Future Medicine

Access to resources Recommend Favorite

Lack of Plasminogen Activator Inhibitor-1 Enhances the Preventive Effect of DX-9065a, a Selective Factor Xa Inhibitor, on Venous Thrombus and Acute Pulmonary Embolism in Mice

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 4, 2004-12 ,pp. : 206-213

Karger

Access to resources Recommend Favorite